Plasma provided by COVID‐19 convalescent patients may provide therapeutic relief as the
number of COVID‐19 cases escalates steeply worldwide. Prior findings in various viral …

The Flavivirus genus is made up of viruses that are either mosquito-borne or tick-borne and
other viruses transmitted by unknown vectors. Flaviviruses present a significant threat to …

Abstract Coronavirus disease 2019 (COVID-19) is a disease caused by infection with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in a pandemic …

We investigated the distribution of antibodies neutralizing SARS-CoV-2 according to age,
sex or blood group in French blood donors. In 464 samples collected before the emergence …

Standard precautions to minimize the risk of SARS-CoV-2 transmission implies that infected
cell cultures and clinical specimens may undergo some sort of inactivation to reduce or …

Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …

Abstract Background Coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP)
collection began in two Brazilian hospitals for treatment of severe/critical patients. Methods …

In the absence of virus-targeting small-molecule drugs approved for the treatment and
prevention of COVID-19, broadening the repertoire of potent SARS-CoV-2-neutralizing …

Background The efficacy of convalescent plasma (CP), an alternative for the treatment of
COVID‐19, depends on high titers of neutralizing antibodies (nAbs), but assays for …

We investigated the anti-SARS-CoV-2 post-vaccine response through serum and salivary
antibodies, serum antibody neutralizing activity and cellular immune response in samples …